Caris Assure Therapy Selection

Caris Assure is a minimally invasive blood test that provides comprehensive molecular analysis of tumor biomarkers when tumor tissue is not available. The assay utilizes circulating Nucleic Acid Sequencing (cNAS), a novel approach to liquid biopsy that analyzes cell-free DNA and RNA from plasma, plus genomic DNA and messenger RNA from circulating white blood cells. Learn more: https://www.carislifesciences.com/physicians/physician-tests/caris-assure/